Biora Therapeutics, Inc. (BIOR) Investment Research Dashboard
About Biora Therapeutics, Inc. (BIOR) stock analysis
Get live BIOR stock price $0.22, comprehensive Biora Therapeutics, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BIOR stock data and investment insights.
Loading chart data...
Biora Therapeutics, Inc. (BIOR) Overview
Biora Therapeutics, Inc. (BIOR) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, BIOR trades at $0.22 with a market capitalization of 994.99K . Over the past 52 weeks, BIOR has traded between $0.15 and $0.38 , with the current price positioned at approximately 30% of this range . The stock currently trades...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 994.99K
- Current price: $0.22
- 52-week range: $0.15 - $0.38
- P/E ratio: 0.61
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Biora Therapeutics, Inc. is a biotechnology company focused on developing cutting-edge oral biotherapeutic solutions. The company's core efforts involve two main therapeutic programs: Targeted Therapeutics: This program utilizes an advanced ingestibl...
Company Information
- CEO
- Aditya Mohanty
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 58
Contact Information
- Address
- 4330 La Jolla Village Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 0.6)
✓ Higher growth potential with elevated volatility (Beta: 1.28)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Biora Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Biora Therapeutics, Inc.
- ⚠Investors should consider how Biora Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
994.99K
P/E Ratio (TTM)
0.61
Beta
1.28
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BIOR with peer companies:
- Price
- $0.04+5.26% (1D)
- Market cap
- 373.69K
- Price
- $0.00-99.46% (1D)
- Market cap
- 1.16M
- Price
- $0.00+9,900.00% (1D)
- Market cap
- 57.19K
- Price
- $1.12+0.00% (1D)
- Market cap
- 1.00M
- Price
- $0.01+2.30% (1D)
- Market cap
- 1.00M
- Price
- $0.00+0.00% (1D)
- Market cap
- 515.88K
- Price
- $0.29+8.62% (1D)
- Market cap
- 2.30M
- Price
- $0.00+0.00% (1D)
- Market cap
- 39.54K
- Price
- $0.40+0.00% (1D)
- Market cap
- 2.07M
- Price
- $0.06+0.00% (1D)
- Market cap
- 965.60K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.